Dog /

Breed profile · FDA CVM July 2026 extract

Bichon Frise adverse-event record

Adverse-event filings for Bichon Frise (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

#33 of 510
by report volume (all breeds)
7,085
FDA CVM reports on file
3.9%
death-coded share of reports
#185 of 275
by death-coded share (≥50 reports)

How the 7,085 reports break down

By recorded gender -- every report on file for Bichon Frise, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 406 304.5 203 101.5 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Bichon Frise drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Bichon Frise ranks #33 of 510 by total reports (7,085) and #185 of 275 by death-coded share (3.9%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#33
This breed, reports of 510
#185
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Bichon Frise has 7,085 reports now versus 7,032 in that prior snapshot: 53 more (0.8%).

Report change
+53
Death-coded reports
+0
Death-coded share
−0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Bichon Frise changes

Total Reports

7,085

Highest-reported breed

Deaths Reported

274

of 7,085 reports

Death-coded share of reports

3.9%

Below-median death-coded share

Avg Age at Report

7.1 yr

7.3 kg avg weight

Breed Safety Scorecard

B (70/100)

A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate B-
3.9%

Share of reports coded as a fatality

Euthanasia rate D
2.2%

Share of reports resulting in euthanasia

Full recovery rate A+
38.3%

Share of reports coded "Recovered/Normal"

5-year trend B
-10%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Bichon Frise death-coded reports 3.9%
Cross-breed median

3.9% of 7,085 bichon frise reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Bichon Frise's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

4% 33rd percentile Higher share than 33% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Bichon Frise 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Bichon Frise among report-volume vs. death-rate peers

Every breed shown has at least 50 filed reports. Volume reflects how often a breed is reported, not how common it is; death rate is the share of a breed's own reports coded as a death outcome.

Source: FDA openFDA Animal & Veterinary Adverse Events database 2×2 strategic matrix plotting 30 entities by Total Reports (X) and Death Rate (%) (Y), with a crosshair dividing the plot into four quadrants. High volume, high death rateLow volume, high death rateHigh volume, low death rateLow volume, low death rate 020,00040,00060,00080,000100,000 0%5%10%15% Total Reports Death Rate (%) Bichon Frise vs. all breeds, report volume and death-coded share Retriever - Labrador-93675, 3.7%Crossbred Canine/dog-70591, 3.2%Domestic Shorthair-65226, 7.2%Dog (unknown)-48820, 8.8%Retriever - Golden-35980, 3.7%Shepherd Dog - German-32220, 4.4%Chihuahua-31521, 4.2%Terrier - Yorkshire-24924, 3.7%Shih Tzu-24405, 3.6%Boxer (German Boxer)-19405, 4.4%Beagle-17970, 3.6%Pit Bull-17865, 3.1%Shepherd Dog - Australian-16274, 3.7%Terrier (unspecified)-14058, 3.1%Maltese-13940, 3.2%Dachshund (unspecified)-13512, 4.6%Cat (unknown)-13248, 9.3%Terrier - Jack Russell-10423, 3.7%Collie - Border-10130, 4.3%Siberian Husky-9811, 4.5%Domestic Longhair-9615, 7%Pug-9224, 5.2%Spitz - German Pomeranian-9086, 4.9%Terrier - Bull - American Pit-8769, 4.7%Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog)-7871, 3.6%Terrier - Boston-7737, 4.5%Spaniel - Cocker American-7640, 4%Domestic (unspecified)-7576, 13.4%Poodle (unspecified)-7534, 3.4%Schnauzer - Miniature-7513, 4.4%
Source: FDA openFDA Animal & Veterinary Adverse Events database
Average weight at time of report: 7.3 kg (16.1 lbs)

Top Reported Reactions

Vomiting 1,814
Emesis 867
Lethargy (see also Central nervous system depression in 'Neurological') 785
Diarrhoea 628
Lack of efficacy (ectoparasite) - flea 462
Lack of efficacy - NOS 333
Anorexia 300
Lack of efficacy (endoparasite) - hookworm 269
Seizure NOS 211
Pruritus 201
Digestive tract disorder NOS 198
Behavioural disorder NOS 186
Other abnormal test result NOS 185
Emesis (multiple) 185
Decreased appetite 171

Most Referenced Drugs

Milbemycin Oxime + Spinosad 1,360
Spinosad 587
Ivermectin + Pyrantel As Pamoate Salt 501
Afoxolaner 488
Oclacitinib Maleate 422
Trilostane 373
Fluralaner Chew Tablets 299
Pyrantel Pamoate;Sarolaner 294
Moxidectin 223
Fluralaner 13.64% 12-Week Chew 180
Carprofen 170
Sarolaner 153
Selamectin 152
Milbemycin Oxime + Praziquantel 150
Maropitant Citrate 135

Outcome Breakdown

Recovered/Normal
2,714 (41.9%)
Outcome Unknown
1,852 (28.6%)
Ongoing
1,469 (22.7%)
Recovered with Sequela
174 (2.7%)
Euthanized
154 (2.4%)
Died
120 (1.9%)

Gender Distribution

Male 3,659 (51.6%)
Female 3,292 (46.5%)
Unknown 125 (1.8%)
Mixed 9 (0.1%)

Reports by Year

Year Reports Trend
2010 303
2011 439
2012 631
2013 624
2014 670
2015 588
2016 551
2017 547
2018 449
2019 406
2020 374
2021 285
2022 306
2023 285
2024 330
2025 257
2026 40

Bichon Frise: low death-coded share in the FDA CVM extract

Signature read: 7,085 reports place Bichon Frise in the upper third of breed filing volume (#33 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Bichon Frise sits at #33 of 510 by report volume among all breeds and #29 of 298 among dog breeds, with 7,085 reports and 274 (3.9%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #185 of 275. Mean age at report: 7.1 years, average weight 7.3 kg (16.1 lbs).

Top reported signs: Vomiting (1,814), Emesis (867), Lethargy (see also Central nervous system depression in 'Neurological') (785). Most-referenced drug: Milbemycin Oxime + Spinosad (1,360 reports), followed by Spinosad (587) and Ivermectin + Pyrantel As Pamoate Salt (501).

Outcome coding on 6,483 status-recorded reports is dominated by Recovered/Normal (41.9%). Annual submissions ranged 40-2,026 across 17 years on file.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

High-volume peer sets for Bichon Frise drawn from openFDA outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (3.9% death-coded here).

Similar average weight

Nearest other-species breeds by reported average weight (7.3 kg here).

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Bichon Frise?
There are 7,085 adverse event reports involving Bichon Frise in the FDA database, of which 274 were death-coded (3.9% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Bichon Frise ranks #33 of 510 by report volume among all breeds PlainBreed indexes (#29 of 298 among dog breeds).
Where does Bichon Frise sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Bichon Frise is #33 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #29 of 298. Among breeds with at least 50 reports, its death-coded share ranks #185 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Bichon Frise?
The most commonly reported adverse reactions for Bichon Frise are Vomiting (1,814 reports), Emesis (867 reports), Lethargy (see also Central nervous system depression in 'Neurological') (785 reports), Diarrhoea (628 reports), Lack of efficacy (ectoparasite) - flea (462 reports).
What drugs are most frequently associated with Bichon Frise adverse events?
The drugs most frequently referenced in Bichon Frise adverse event reports are Milbemycin Oxime + Spinosad (1,360 reports), Spinosad (587 reports), Ivermectin + Pyrantel As Pamoate Salt (501 reports), Afoxolaner (488 reports), Oclacitinib Maleate (422 reports).
What is the average age of Bichon Frise in adverse event reports?
The average age of Bichon Frise at the time of adverse event reports is 7.1 years, with an average weight of 7.3 kg (16.1 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Bichon Frise (Dog), extract as of July 2026 extract. 7,085 reports · 274 death-coded (3.9% of reports, not a mortality rate) · #33 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →